Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
2004 2
2005 1
2007 1
2008 1
2009 2
2011 3
2012 3
2013 6
2014 6
2015 6
2016 4
2017 4
2018 4
2019 3
2020 9
2021 16
2022 22
2023 22
2024 6

Text availability

Article attribute

Article type

Publication date

Search Results

99 results

Results by year

Filters applied: . Clear all
Page 1
Efficacy and safety of aldosterone synthase inhibition with and without empagliflozin for chronic kidney disease: a randomised, controlled, phase 2 trial.
Tuttle KR, Hauske SJ, Canziani ME, Caramori ML, Cherney D, Cronin L, Heerspink HJL, Hugo C, Nangaku M, Rotter RC, Silva A, Shah SV, Sun Z, Urbach D, de Zeeuw D, Rossing P; ASi in CKD group. Tuttle KR, et al. Lancet. 2024 Jan 27;403(10424):379-390. doi: 10.1016/S0140-6736(23)02408-X. Epub 2023 Dec 15. Lancet. 2024. PMID: 38109916 Clinical Trial.
[Translated article] Pharmacokinetics of eculizumab in adult and pediatric patients with atypical hemolytic uremic syndrome and C3 glomerulopathy.
Parra AP, Ramos N, Perurena-Prieto J, Manrique-Rodríguez S, Climente M, Quintanilla LG, Escolano Á, Miarons M; grupo PK-ECU-ORPHAR. Parra AP, et al. Among authors: ramos n. Farm Hosp. 2024 Jan-Feb;48(1):T16-T22. doi: 10.1016/j.farma.2023.09.009. Epub 2023 Dec 5. Farm Hosp. 2024. PMID: 38057242 Free article. English, Spanish.
Pharmacokinetics of eculizumab in adult and pediatric patients with atypical hemolytic uremic syndrome and C3 glomerulopathy.
Pau Parra A, Ramos N, Perurena-Prieto J, Manrique-Rodríguez S, Climente M, García Quintanilla L, Escolano Á, Miarons M; en nombre del grupo PK-ECU-ORPHAR. Pau Parra A, et al. Among authors: ramos n. Farm Hosp. 2024 Jan-Feb;48(1):16-22. doi: 10.1016/j.farma.2023.07.009. Epub 2023 Aug 22. Farm Hosp. 2024. PMID: 37612186 Free article. English, Spanish.
99 results